Legal Representation
Attorney
Francis J. Duffin
USPTO Deadlines
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 29, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jun 29, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Nov 1, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 31, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Oct 31, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Oct 30, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 30, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
May 18, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 16, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 16, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
May 16, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Nov 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Nov 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 13, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Nov 13, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
May 12, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 10, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 10, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
May 10, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Oct 26, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 24, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 24, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Oct 24, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
May 23, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 28, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 28, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 8, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 16, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 26, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 25, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 25, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 25, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 25, 2016 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Jul 25, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 23, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 18, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 17, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Feb 17, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Aug 26, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 26, 2015 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Aug 26, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 4, 2015 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Aug 4, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Aug 4, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 23, 2015 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Mar 23, 2015 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Mar 23, 2015 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Feb 10, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 9, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Feb 9, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"